| Primary |
| Drug Use For Unknown Indication |
26.1% |
| Chronic Lymphocytic Leukaemia |
25.2% |
| Non-hodgkin's Lymphoma |
13.4% |
| Chronic Lymphocytic Leukaemia Refractory |
5.0% |
| Mantle Cell Lymphoma Stage Iv |
3.4% |
| Nephrotic Syndrome |
2.5% |
| Rheumatoid Arthritis |
2.5% |
| B-cell Lymphoma |
1.7% |
| Constipation |
1.7% |
| Deep Vein Thrombosis |
1.7% |
| Drug Dispensing Error |
1.7% |
| Herpes Virus Infection |
1.7% |
| Hypothyroidism |
1.7% |
| Lymphocytic Leukaemia |
1.7% |
| Lymphoma |
1.7% |
| Migraine |
1.7% |
| Product Used For Unknown Indication |
1.7% |
| Prophylaxis |
1.7% |
| Prostate Cancer |
1.7% |
| Sinusitis |
1.7% |
|
| Death |
11.4% |
| Dyspnoea |
8.6% |
| Rash |
8.6% |
| Pneumonia |
7.1% |
| White Blood Cell Count Increased |
7.1% |
| Respiratory Tract Infection |
5.7% |
| Skin Burning Sensation |
5.7% |
| Yellow Skin |
5.7% |
| Medication Error |
4.3% |
| Myelodysplastic Syndrome |
4.3% |
| Pyrexia |
4.3% |
| Respiratory Distress |
4.3% |
| Anaemia Haemolytic Autoimmune |
2.9% |
| Disease Progression |
2.9% |
| Drug Administration Error |
2.9% |
| Drug Ineffective |
2.9% |
| Ear Infection |
2.9% |
| Nausea |
2.9% |
| Night Sweats |
2.9% |
| Pharmaceutical Product Complaint |
2.9% |
|
| Secondary |
| Behcet's Syndrome |
64.9% |
| Product Used For Unknown Indication |
17.7% |
| Chronic Lymphocytic Leukaemia |
3.5% |
| B-cell Lymphoma |
2.8% |
| Immunodeficiency Common Variable |
2.1% |
| Waldenstrom's Macroglobulinaemia |
2.1% |
| Actinic Keratosis |
1.0% |
| Ankylosing Spondylitis |
1.0% |
| Hairy Cell Leukaemia |
1.0% |
| Hodgkin's Disease |
1.0% |
| Hypertension |
0.7% |
| Renal Failure |
0.7% |
| Rheumatoid Arthritis |
0.7% |
| Extrasystoles |
0.3% |
| Multiple Myeloma |
0.3% |
|
| Squamous Cell Carcinoma Of Skin |
25.0% |
| Skin Cancer |
15.0% |
| Squamous Cell Carcinoma |
10.0% |
| General Physical Health Deterioration |
5.0% |
| Rash |
5.0% |
| Resuscitation |
5.0% |
| Anaemia |
2.5% |
| Colon Cancer |
2.5% |
| Death |
2.5% |
| Dehydration |
2.5% |
| Drug Dispensing Error |
2.5% |
| Epilepsy |
2.5% |
| Extrasystoles |
2.5% |
| Febrile Neutropenia |
2.5% |
| Haemorrhage |
2.5% |
| Hepatitis B Virus Test |
2.5% |
| Hypophagia |
2.5% |
| Mouth Ulceration |
2.5% |
| Myelodysplastic Syndrome |
2.5% |
| Nephrolithiasis |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.6% |
| Chronic Lymphocytic Leukaemia |
13.9% |
| Drug Use For Unknown Indication |
10.5% |
| Nephrotic Syndrome |
6.0% |
| Non-hodgkin's Lymphoma |
5.6% |
| Idiopathic Thrombocytopenic Purpura |
4.9% |
| Chemotherapy |
4.5% |
| Multiple Myeloma |
3.4% |
| Anaemia |
3.0% |
| B-cell Lymphoma |
3.0% |
| Anaemia Of Malignant Disease |
2.2% |
| Helicobacter Infection |
2.2% |
| Rheumatoid Arthritis |
1.9% |
| Benign Prostatic Hyperplasia |
1.5% |
| Blood Pressure |
1.5% |
| Hypertension |
1.5% |
| Prophylaxis |
1.5% |
| Diabetes Mellitus |
1.1% |
| Immunosuppression |
1.1% |
| Insomnia |
1.1% |
|
| Upper Respiratory Tract Infection |
10.9% |
| Pyrexia |
9.1% |
| Vision Blurred |
7.3% |
| Chronic Lymphocytic Leukaemia |
5.5% |
| Myelodysplastic Syndrome |
5.5% |
| Progressive Multifocal Leukoencephalopathy |
5.5% |
| Respiratory Tract Infection |
5.5% |
| Splenomegaly |
5.5% |
| Thrombocytopenia |
5.5% |
| Weight Decreased |
5.5% |
| Aplasia Pure Red Cell |
3.6% |
| Cardiac Arrest |
3.6% |
| Death |
3.6% |
| Drug Ineffective |
3.6% |
| Glomerulonephritis Chronic |
3.6% |
| Jaundice Cholestatic |
3.6% |
| Metastases To Peritoneum |
3.6% |
| Pancytopenia |
3.6% |
| Sequestrectomy |
3.6% |
| Agranulocytosis |
1.8% |
|
